Search research articles
Contact Us
Filters
Showing results (101-110 of 138) with videos related to
Page
of 14
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 2, 2011
Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology Group
David A Rodeberg, Norbert Garcia-Henriquez, Elizabeth R Lyden, et al.
Pediatric Blood & Cancer
|
May 17, 2013
Relapse after treatment of pediatric Hodgkin lymphoma: outcome and role of surveillance after end of therapy
Alison M Friedmann, Julie A Wolfson, Melissa M Hudson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2003
Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study
Roger J Packer, James G Gurney, Judy A Punyko, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 5, 2020
Virtual Radiation Oncology Clerkship During the COVID-19 Pandemic and Beyond
Navjot Sandhu, Jessica Frank, Rie von Eyben, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 20, 2007
Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease
Sarah S Donaldson, Michael P Link, Howard J Weinstein, et al.
Radiation Research
|
September 30, 2006
Thyroid cancer in childhood cancer survivors: a detailed evaluation of radiation dose response and its modifiers
Cécile M Ronckers, Alice J Sigurdson, Marilyn Stovall, et al.
Blood
|
February 9, 2008
Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study
Elizabeth C Bluhm, Cécile Ronckers, Robert J Hayashi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 23, 2009
Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803
Carola A S Arndt, Julie A Stoner, Douglas S Hawkins, et al.
Pediatric Blood & Cancer
|
August 14, 2013
The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study
Daniel M Green, Vikki G Nolan, Pamela J Goodman, et al.
The Lancet. Oncology
|
March 30, 2016
Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort
Eric J Chow, Kayla L Stratton, Wendy M Leisenring, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 138) with videos related to
Sort By:
Page
of 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 2, 2011
Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology Group
David A Rodeberg, Norbert Garcia-Henriquez, Elizabeth R Lyden, et al.
Pediatric Blood & Cancer
|
May 17, 2013
Relapse after treatment of pediatric Hodgkin lymphoma: outcome and role of surveillance after end of therapy
Alison M Friedmann, Julie A Wolfson, Melissa M Hudson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2003
Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study
Roger J Packer, James G Gurney, Judy A Punyko, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 5, 2020
Virtual Radiation Oncology Clerkship During the COVID-19 Pandemic and Beyond
Navjot Sandhu, Jessica Frank, Rie von Eyben, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 20, 2007
Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease
Sarah S Donaldson, Michael P Link, Howard J Weinstein, et al.
Radiation Research
|
September 30, 2006
Thyroid cancer in childhood cancer survivors: a detailed evaluation of radiation dose response and its modifiers
Cécile M Ronckers, Alice J Sigurdson, Marilyn Stovall, et al.
Blood
|
February 9, 2008
Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study
Elizabeth C Bluhm, Cécile Ronckers, Robert J Hayashi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 23, 2009
Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803
Carola A S Arndt, Julie A Stoner, Douglas S Hawkins, et al.
Pediatric Blood & Cancer
|
August 14, 2013
The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study
Daniel M Green, Vikki G Nolan, Pamela J Goodman, et al.
The Lancet. Oncology
|
March 30, 2016
Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort
Eric J Chow, Kayla L Stratton, Wendy M Leisenring, et al.
Page
of 14